
Wilcure Remedies Private Limited
Pharmaceutical trading company offering a variety of products such as tablets, capsules, and syrups.
Pharmaceutical trading company offering a variety of products such as tablets, capsules, and syrups.
Wilcure Remedies Private Limited (WRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 08 October 2004 and has a history of 20 years and seven months. Its registered office is in Indore, Madhya Pradesh.
The Corporate was formerly known as Vostok And Wilcure Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.59 M.
The company currently has active open charges totaling ₹6.70 Cr. The company has closed loans amounting to ₹4.93 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jay Saraf, Devendra Saraf, and Shailendra Saraf serve as directors at the Company.
+91-XXXXXXXXXX
U24232MP2004PTC017022
017022
Private Limited Indian Non-Government Company
08 Oct 2004
28 Sep 2023
31 Mar 2023
Unlisted
Roc Gwalior
Wilcure Remedies Private Limited offers a wide range of products and services, including Antacid Drugs, Omeprazole Capsule, Mineral Supplement, Calcium Tablet, Common Disease Medicines, Pharmaceutical Tablets, Nutraceuticals & Dietary Supplements, Antihistamines, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jay Saraf ![]() | Director | 08-Oct-2004 | Current |
Devendra Saraf ![]() | Director | 08-Oct-2004 | Current |
Shailendra Saraf ![]() | Director | 08-Oct-2004 | Current |
Wilcure Remedies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.72% decrease. The company also saw a substantial fall in profitability, with a 26.24% decrease in profit. The company's net worth Soared by an impressive increase of 18.41%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Wilcure Remedies had a promoter holding of 0.28% and a public holding of 99.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹67.01 M
₹49.30 M
Date | Lender | Amount | Status |
---|---|---|---|
08 Apr 2024 | Others | ₹1.55 M | Open |
05 Aug 2022 | Others | ₹4.50 Cr | Open |
04 Aug 2022 | Others | ₹1.00 Cr | Open |
15 Jul 2022 | Others | ₹1.06 M | Open |
27 Aug 2020 | Others | ₹7.50 M | Open |
Wilcure Remedies has a workforce of 7 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Wilcure Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wilcure Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 1.55 M with Charge ID 100911794 was registered on 08 Apr 2024.
Wilcure Remedies Private Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records.
Wilcure Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Gwalior.
A charge registered on 09 Aug 2012 via Charge ID 10373400 with Others was fully satisfied on 08 Aug 2022.
A charge with Others amounted to Rs. 45.00 M with Charge ID 100600267 was registered on 05 Aug 2022.
A charge with Others amounted to Rs. 10.00 M with Charge ID 100600276 was registered on 04 Aug 2022.
Wilcure Remedies Private Limited was incorporated on 08 Oct 2004.
The authorized share capital of Wilcure Remedies Private Limited is ₹ 4.00 M and paid-up capital is ₹ 3.59 M.
Currently 3 directors are associated with Wilcure Remedies Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Wilcure Remedies Private Limited is 101 Vishnupuri Main, India, Indore, Madhya Pradesh.
The corporate identification number (CIN) of Wilcure Remedies Private Limited is U24232MP2004PTC017022 and the company number is 017022 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Wilcure Remedies Private Limited has fallen by -12.72%.
As Per 2023 financial reports, 7 employees are currently employed by Wilcure Remedies Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Wilcure Remedies Private Limited has experienced an upsurge of 18.41%.
As per the financial statements for fiscal Year 2023, The total open charges for Wilcure Remedies Private Limited amount to ₹ 6.70 Cr.
The most recent Balance Sheet for Wilcure Remedies Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.